» Authors » Anissa Bouzamondo

Anissa Bouzamondo

Explore the profile of Anissa Bouzamondo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 329
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Richalet J, Gimenez-Roqueplo A, Peyrard S, Venisse A, Marelle L, Burnichon N, et al.
Clin Auton Res . 2009 Sep; 19(6):335-42. PMID: 19768395
The detection of hypoxia by the carotid bodies elicits a ventilatory response of utmost importance for tolerance to high altitude. Germline mutations in three genes encoding subunit B, C and...
2.
Jondeau G, Neuder Y, Eicher J, Jourdain P, Fauveau E, Galinier M, et al.
Eur Heart J . 2009 Sep; 30(18):2186-92. PMID: 19717851
Aims: Whether or not beta-blocker therapy should be stopped during acutely decompensated heart failure (ADHF) is unsure. Methods And Results: In a randomized, controlled, open labelled, non-inferiority trial, we compared...
3.
Barthelemy O, Jacqueminet S, Rouzet F, Isnard R, Bouzamondo A, Le Guludec D, et al.
Arch Cardiovasc Dis . 2008 Dec; 101(9):539-46. PMID: 19041838
Background: Screening for silent myocardial ischaemia (SMI) is a controversial strategy undergoing intensive risk factor therapy. Aims: To assess the prevalence of SMI and coronary artery disease (CAD) in asymptomatic...
4.
Amiet C, Gourfinkel-An I, Bouzamondo A, Tordjman S, Baulac M, Lechat P, et al.
Biol Psychiatry . 2008 Jun; 64(7):577-82. PMID: 18565495
Background: The association between epilepsy and autism is consistently reported, with a wide range of prevalence rates. This may be attributed to the heterogeneity of the samples with respect to...
5.
Consoli A, Bouzamondo A, Guile J, Lechat P, Cohen D
Can J Psychiatry . 2007 Jun; 52(5):323-8. PMID: 17542383
Objective: To assess whether comorbid attention-deficit hyperactivity disorder (ADHD) influences response to treatment in young patients with acute mania. Methods: We conducted a metaanalysis of 5 open trials of 100,...
6.
Lebrun-Vignes B, Bouzamondo A, Dupuy A, Guillaume J, Lechat P, Chosidow O
J Am Acad Dermatol . 2007 Apr; 57(2):238-46. PMID: 17416440
Background: Efficacy of oral antiviral therapies, ie, acyclovir, valacyclovir (VACV), and famciclovir, for suppression of recurrent genital herpes was studied at different doses and regimens. Objective: We sought to compare...
7.
Abi Nasr I, Bouzamondo A, Hulot J, Dubourg O, Le Heuzey J, Lechat P
Eur Heart J . 2007 Feb; 28(4):457-62. PMID: 17289748
Aims: Atrial fibrillation (AF) is an important morbidity-mortality risk factor, especially in patients with heart failure (HF). Beta-blockers reduce morbidity and mortality in HF. The study was designed to estimate...
8.
Borentain M, Montalescot G, Bouzamondo A, Choussat R, Hulot J, Lechat P
Catheter Cardiovasc Interv . 2005 May; 65(2):212-21. PMID: 15900551
This meta-analysis assessed the rates of the efficacy and safety endpoints with intravenous low-molecular-weight heparin (LMWH) compared with unfractionated heparin (UFH) in patients undergoing percutaneous coronary intervention (PCI). Subcutaneous LMWH...
9.
Hulot J, Vantelon C, Urien S, Bouzamondo A, Mahe I, Ankri A, et al.
Ther Drug Monit . 2004 May; 26(3):305-10. PMID: 15167633
The use of weight-adjusted enoxaparin dosage in patients with renal failure results in increased bleeding complications. The authors investigated the impact of patient-related factors such as renal function on the...
10.
Corvol J, Bouzamondo A, Sirol M, Hulot J, Sanchez P, Lechat P
Therapie . 2003 Jun; 58(1):37-48. PMID: 12822199
Background: Previous overviews have suggested that the HMG-CoA reductase inhibitors (statins), but not other lipid lowering therapies (LLTs), may reduce stroke incidence in coronary patients. Our objective was to investigate...